Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Leo Pharma AS

Closing information (x1000 NOK)

Closing information 2023/12 2022/12 2021/12
Turnover 44,517 More Arrow 48,996 More Arrow 54,067
Financial expenses 40 More Arrow 131 Less Arrow 83
Earnings before taxes 2,411 Less Arrow 2,011 Less Arrow 684
Total assets 39,507 Less Arrow 33,044 Less Arrow 29,475
Current assets 39,504 Less Arrow 33,040 Less Arrow 29,468
Current liabilities 21,715 Less Arrow 17,131 Less Arrow 15,127
Equity capital 17,792 Less Arrow 15,912 Less Arrow 14,349
- share capital 3,000 Equal arrow 3,000 Equal arrow 3,000

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 45.0% More Arrow 48.2% More Arrow 48.7%
Turnover per employee
Profit as a percentage of turnover 5.4% Less Arrow 4.1% Less Arrow 1.3%
Return on assets (ROA) 6.2% More Arrow 6.5% Less Arrow 2.6%
Current ratio 181.9% More Arrow 192.9% More Arrow 194.8%
Return on equity (ROE) 13.6% Less Arrow 12.6% Less Arrow 4.8%
Change turnover -4,479 Less Arrow -5,071 Less Arrow -20,275
Change turnover % -9% Equal arrow -9% Less Arrow -27%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.